A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis. Trojano M, Ramio-Torrenta L, Grimaldi LM, Lubetzki C, et al. Mult Scler 2021 Apr 6:13524585211003020. doi: 10.1177/13524585211003020.

Read + Share

Amedeo Smart

Independent Medical Education

Trojano M, Ramio-Torrenta L, Grimaldi LM, Lubetzki C, et al. A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis. Mult Scler 2021 Apr 6:13524585211003020. doi: 10.1177/13524585211003020.
PMID: 33821693